Department of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University, Medyczna 9, 30-688 Cracov, Poland
Bibliografia
AGA, H., SHIHUYA, T., SUGIMOTO, T., KURIMOTO, M. and S. NAKAJIMA. 1994. Isolation and identification of antimicrobial compounds in Brazilian propolis. Biosci. Biotech. Biochem. 58: 945—946.
BANSKOTA, A.H., TEZUKA, Y. and S. KADOTA. 2001. Recent progress in pharmacological research of propolis. Phytother. Res. 15: 561-571.
BANSKOTA, A.H., TEZUKA, Y., ADNYANA, I.K., MIDORIKAWA, K., Matsushige, K, Message D., Huertas A.A., and S. Kadota. 2000. Cytotoxic, hepatoprotective and free radical scavenging effects of propolis from Brazil, Peru, the Netherlands and China. J. Ethnopharmacol. 72: 239- -246.
BAZO, A.P., RODRIGUES, M.A., SFORCIN, J.M., DE CAMARGO, J.L., RIBEIRO, L.R. and D.M. SALVADORI. 2002. Protective action of propolis on the rat colon carcinogenesis. Teratog. Carcinog. Mutagen. 22: 183-194.
BELOSTOTSKIJ, N.I., KAS’IANENKO, V.I., DUBTSOVA, E.A. and L.B. LAZEBNIK. 2009. Influence of honey, royal jelly and propolis on accelerating acetate healing of experimental gastric ulcers in rats. Eksp Klin Gastroenterol. 6: 46-50.
BOYANOVA, L., DEREJIAN, S., KOUMANOVA, R., KATSAROV, N., GERGOVA, G., MITOV, I., NIKOLOV, R. and Z. KRASTEV. 2003. Inhibition of Helicobacter pylori growth in vitro by Bulgarian propolis: preliminary report. J. Med. Microbiol. 52: 417-419.
BURDOCK, G.A. 1998. Review of the biological properties and toxicity of bee propolis (Propolis). Food Chem. Toxicol. 36: 347-363.
CASTALDO, S. and F. CAPASSO. 2002. Propolis, an old remedy used in modern medicine. Fitoterapi, 73: 1-6.
CHOPRA, S., PILLAI, K.K., HUSAIN, S.Z., and D.K. GIRI. 1995. Propolis protects against doxorubicin-induced myocardiopathy in rats. Ex. Mol. Pathol, 62: 190-198.
CIZMARIK J. and N. LAHITOVA. 1998. Antimutagenicity of propolis. Pharmazie 53: 883-884.
DUARTE, S., KOO, H., BOWEN, W.H., HAYACIBARA, M.F., CURY, J.A., IKEGAKI, M. and P.L. ROSALEN. 2003. Effect of a novel type of propolis and its chemical fractions on glucosyltransferases and on growth and adherence of mutans streptococci. Biol. Pharm. Bull. 26: 527-531.
GREGORY, S.R., PICCOLO, N., PICCOLO, M.T., PICCOLO, M.S. and J.P. HEGGERS. 2002. Comparison of propolis skin cream to silver sulfadiazine: a naturopathic alternative to antibiotics in treatment of minor bums. J. Altern. Complement. Med. 8: 77-83.
HARTWICH, A., LEGUTKO, J. and J. WSZOLEK. 2000. Propolis: its properties and administration to patients treated for some surgical diseases. Przegl. Lek. 57: 191-194.
HAVSTEEN, BH. 2002. The biochemistry and medical signifi¬cance of the flavonoids. Pharmacol Ther. 96: 67-202.
KESKIN, N., HAZIR, S., BASER, K.H. and KURKCUOGLU. 2001. Antibacterial activity and chemical composition of Turkish propolis. Z. Naturforsch. (C). 56: 1112-1115.
KIDERMAN, A., TORTEN, R., FURST, A.L. and K. REINUS. 2001. Bi-lateral eosinophilic ulcers in an infant treated with propolis. J. Dermatolog. Treat. 12: 29-31.
Koo, H., ROSALEN, P.L., CURY, J.A., PARK, Y.K. and W.H. BOWEN. 2002. Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. Antimicrob. Agents Chemother. 46: 1302-1309.
KRASNODĘBSKI, J., SCHELLER, S. and H. SUCHY. 1986. Zastosowanie etanolowego ekstraktu propolisu (EEP) w leczeniu stanów zapalnych pochwy oraz stanów po elektrokoagulacji nadżerek szyjki macicy. Gin. Pol. 57: 471-478.
KUJUMGIEV, A., TSVETKOVA, L, SERKEDJIEVA, Y., BANKOVA, V., CHRISTOV, R. and S. POPOV. 1999. Antibacterial, antifungal and antiviral activity of propolis of different geographic origin. J. Ethnopharmacol. 64: 235-240.
LIN, S.C., CHUNG, C.Y., CHIANG, C.L. and S.H. Hsu. 1999. The influence of propolis ethanol extract on liver microsomal enzymes and glutathione after chronic alcohol admini¬stration. Am. J. Chin. Med. 27: 83-93.
Luo, J., SOH, J.W., XING, W.Q., MAO, Y., MATSUNO, T. and I.B. WEINSTEIN. 2001. PM-3, a benzo-gamma-pyran derivative isolated from propolis, inhibits growth of MCF-7 human breast cancer cells. Anticancer Res. 21: 1665-1671.
MARCUCCI M. C. 1995. Propolis: chemical composition, biological properties and therapeutic activity. Apidologie 26: 83-99.
MIDORIKAWA, K, BANSKOTA, A.H., TEZUKA, Y., NAGAOKA, T., MATSUSHIGE, K., MESSAGE, D., HUERTAS, A.A. and S. KADOTA. 2001. Liquid chromatography-mass spectrometry analysis of propolis. Phytochem. Anal., 12: 366-373.
OKABE, S., TAKAGI K. and K. INOUE. 1993. Effect of NC-1300-0-3 on healing of acetic acid-induced gastric ulcers in rats. Jpn. J. Pharmacol. 62: 25-33.
OKABE, S., TAKAGI, K, IGATA, H., KATO, S., SHIMOSAKO, K., YAMAJI, Y. and M. SEIKI. 1992. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine. Jpn. J. Pharmacol. 59: 275-289.
OKABE, S., TAKEUCHI, K, MURATA, T. and K TAKAGI. 1997. Effects of cimetidine and atropine sulfate on gastric secretion and healing of gastric and duodenal ulcers in rats. Eur. J. Pharmacol. 41: 205-208.
OKABE, S., TAKEUCHI, K., MURATA, T. and T. URUSHIDANI. 1978. Effects of cimetidine on healing of chronic gastric and duodenal ulcers in dogs. Am J Dig Dis. 23: 166-168.
OKABE, S., TAKEUCHI, K., URUSHIDANI, T. and K. TAKAGI. 1977. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers. Am J Dig Dis. 22: 677-684.
PAULINO, N., DANTAS, A.P., BANKOVA, V., LONGHI, D.T., SCREMIN, A., DE CASTRO, S.L. and J.B. CALIXTO. 2003. Bulgarian propolis induces analgesic and anti-inflammatory effects in mice and inhibits in vitro contraction of airway smooth muscle. J. Pharmacol. Sci. 93: 307-313.
PAULINO, N., SCREMIN, F.M., RAICHASKI, L.B., MARCUCCI, M.C., SCREMIN A. and J.B. CALIXTO. 2002. Mechanisms involved in the relaxant action of the ethanolic extract of propolis in the guinea-pig trachea in-vitro. J. Pharm. Pharmacol. 54: 845-852.
PIETTA, P.G., GARDANA, C. and A.M. PIETRA. 2002. Analytical methods for quality control of propolis. Fitoterapia 73: 7-20.
SANTOS, F.A., BASTOS, E.M., UZEDA, M., CARVALHO, M.A., FARIAS, L.M., MOREIRA, E.S. and F.C. BRAGA. 2002. Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria. J. Ethnopharmacol. 80: 1-7.
SCHELLER, S., ZAPOTOCZNY, S., KUBACKA, S., TUSTANOWSKI, J. and S. SZYSZKO. 1980. Zastosowanie metanolowego ekstraktu propolisu (EEP) w chirurgii. Przegl. Lek. 37: 739-741.
SONG, Y.S., PARK, E.H., JUNG, K. J. and C. JIN. 2002. Inhibition of angiogenesis by propolis. Arch. Pharm. Res. 25: 500-504.
STEPANOVIC, S., ANTIC, N., DAKIC, I. and M. SVABIC-VLAHOVIC. 2003. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol. Res. 158: 353-357.
SUCHY, H., ZAWADZKI, J., SCHELLER, S. and A. Posz. Dalsze badania nad zastosowaniem propolisu w ginekologii. Przeg. Lek. 31: 646-648.
TAKAGI, K. and S. OKABE. 1969. An experimental gastric ulcer of the rat produced with anticholinergic drugs under stress. Eur. J. Pharmacol. 5: 263-271.
TAKAGI, K., OKABE, S. and R. SAZIKI. 1969. A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn. J. Pharmacol. 19: 418-426.